Based on these findings, even when TAFRO patients meet the criteria for SLE or SS, they may not be typical cases but rather belong to a group of disorders characterized by the presence of anti-SSA/Ro60 antibodies. This evidence concerns the gene TRIM21 and systemic lupus erythematosus.